AzTrials
AzTrials

SCI - Spinal Cord InjuryNCT03352505

Cardiovascular Risk Markers in Spinal Cord Injured Subjects of the Wheelchair Dancer Study

An observational study of SCI - Spinal Cord Injury and Cardiovascular Risk Factor, run by Paracelsus Medical University at 2 sites in Austria.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The present study will analyze if exercise is able to elicit the well-known anti-atherogenic effects in patients with SCI. This will be evaluated by measuring vascular parameters such as endothelial and inflammatory blood markers, echocardiography of the heart and peripheral vessels, as well as blood pressure and… Read more about this study

Who is it for?
Ages 18 to 80 yearsHealthy volunteers can take part
How many people
54 participants
Where
2 sitesAustria
Study dates
1 Oct 2017to 28 Jan 2021
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: healthy participants, wheelchair users

Who may be able to join

  • wheelchair users independent of the cause of the walking impairment, preferably with spinal cord injury.

Who cannot join

  • metallic implanters, additional neurologic pathologies, pregnancy

Trial locations and contacts

2 sites in 1 country.

Austria2 sites
  • Department of Neurology, Christian Doppler Klinik, Paracelsus Medical University Salzburg

    Salzburg, 5020

  • Department of Sports Medicine, Prevention and Rehabilitation Paracelsus Medical University

    Salzburg, 5020

Other trials in Austria

About this study

Official title: Associations Between the Cardiovascular Risk Markers and Neuroplasticity in Sedentary or Physically Active Spinal Cord Injured Subjects of the Wheelchair Dancer Study

The present study will analyze if exercise is able to elicit the well-known anti-atherogenic effects in patients with SCI. This will be evaluated by measuring vascular parameters such as endothelial and inflammatory blood markers, echocardiography of the heart and peripheral vessels, as well as blood pressure and arterial stiffness, in subjects performing either wheelchair dancing, wheelchair marathon or no sports. Further, it will be investigated, whether there is an association between neuroplasticity and cardiovascular health, as measured by electroencephalography (EEG), transcranial magnetic stimulation (TMS) and blood levels of the brain-derived neurotrophic factor (BDNF).

We hypothesize that the cardiovascular, physical and psychological benefits of wheelchair dancing and/or wheelchair marathon parallel improved neuroplasticity in SCI-patients

Medical subject headings
Spinal Cord Injuries

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT03352505
Study groupRoleWhat they receive
controlhealthy walking control participants
wheelchair dancerwheelchair users, who are performing wheelchair dancing
wheelchair marathon participantswheelchair users, who are participants in wheelchair/ handbike Marathon competitions
sedentary wheelchair patientswheelchair users, who conduct exercise bouts less than 2 times per month

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. comparison of cardiovascular risk factors between different study groups

    measurement for arterial stiffness parameters, via pulse wave analysis. Comparison between healthy individuals and patients using wheelchairs (three different groups).

    Measured: October 2017- June 2018

  2. Evaluation of echocardiography results between different study groups

    Evaluation of echocardiography comparing healthy individuals and patients using wheelchairs (three different groups).

    Measured: October 2017- June 2018

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Nov 2017
  2. Study start1 Oct 2017
  3. Primary completion1 Oct 2019
  4. Study completion28 Jan 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Prospective
Enrolment
54 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03352505
Sponsor's protocol ID
UISM-12
Status last verified
Jan 2021
First submitted
16 Nov 2017
Last updated
29 Jan 2021
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of SCI - Spinal Cord Injury and Cardiovascular Risk Factor, run by Paracelsus Medical University at 2 sites in Austria.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 29 Jan 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Austria. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

comparison of cardiovascular risk factors between different study groups (time frame: October 2017- June 2018). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Jan 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in